Literature DB >> 31292805

Contribution of Sociodemographic, Clinical, and Psychological Variables to Quality of Life in Women with Cervical Cancer in the Follow-Up Phase.

Ana Clara Lopes1, Rosário Bacalhau1, Martim Santos1, Marta Pereira1, M Graça Pereira2.   

Abstract

This study evaluates the contribution of sociodemographic, clinical, and psychological variables to quality of life (QoL) of women with cervical cancer in the follow-up phase. This cross-sectional study, conducted at the Portuguese Oncology Institute of Lisbon, included 200 women with cervical cancer during follow-up. Patients were assessed on QoL (EORTC QLQ-C30), body image and specific symptoms (EORTC QLQ-CX24), psychological morbidity (HADS), social support (SSSS), emotional expression (CECS), and spirituality (SpREUK). Education and social support contributed positively to QoL, whereas body image and symptoms contributed negatively. Body image played a moderating role in the relationship between depression and QoL, but not between anxiety and QoL. Spirituality and emotional expression did not moderate the relationship between anxiety/depression and QoL. Health professionals should reference and monitor women with cervical cancer, providing support at the diagnosis and follow-up phase since physical and psychological symptoms, resulting from the disease, remain after the end of treatment and contribute negatively to their QoL. Interventions should focus on these particular outcomes to promote patients' QoL.

Entities:  

Keywords:  Cervical cancer; Emotional expression; Follow-up; Quality of life; Spirituality

Mesh:

Year:  2020        PMID: 31292805     DOI: 10.1007/s10880-019-09644-0

Source DB:  PubMed          Journal:  J Clin Psychol Med Settings        ISSN: 1068-9583


  1 in total

1.  The Importance of Social Support, Optimism and Resilience on the Quality of Life of Cancer Patients.

Authors:  Iván Ruiz-Rodríguez; Isabel Hombrados-Mendieta; Anabel Melguizo-Garín; María José Martos-Méndez
Journal:  Front Psychol       Date:  2022-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.